Socially Responsible Investors Back FDA’s New Look at BPA Safety

A coalition of investors and other groups representing over $26 billion in assets this week sent a letter to Margaret Hamburg, commissioner of the Food and Drug Administration, applauding her recent decision to reassess the safety of bisphenol A (BPA), a controversial chemical used in can linings and hard plastics.

WASHINGTON — A coalition of investors and other groups representing over $26 billion in assets this week sent a letter to Margaret Hamburg, commissioner of the Food and Drug Administration, applauding her recent decision to reassess the safety of bisphenol A (BPA), a controversial chemical used in can linings and hard plastics.

Register to view the full article